COMPANY

Serpin Pharma

HQ: Manassas, VA source · serpinpharma.com ↗ · Southeast

Location: Manassas, VA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Aug 18, 2025 Grant Government grant — SBIR: $625,359 (annual award, as published), announced Aug 18, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Last 2 years.

Aug 18, 2025 Government grant — SBIR: $625,359 (annual award, as published), announced Aug 18, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Annual award amounts. Total $1.6M.

Sep 16, 2024 NIH award 2R44CA268700-02A1 FY2024: $838,708 awarded for that fiscal year; activity R44 (SBIR); PI GELBER, COHAVA; recipient as written: SERPIN PHARMA, LLC, Manassas, VA. A Novel LRP1 Agonist, SP16, as a Therapeutic source ↗
Sep 19, 2022 NIH award 1R43CA268700-01A1 FY2022: $398,816 awarded for that fiscal year; activity R43 (SBIR); PI GELBER, COHAVA; recipient as written: SERPIN PHARMA, LLC, Manassas, VA. Pre-clinical validation of Phase II peptide L source ↗
Jul 18, 2014 NIH award 1R43DK101203-01 FY2014: $188,508 awarded for that fiscal year; activity R43 (SBIR); PI MOGELSVANG, SOREN; recipient as written: SERPIN PHARMA, LLC, Manassas, VA. Development of a new anti-inflammatory pepti source ↗
Feb 1, 2013 NIH award 1R43DK097853-01 FY2013: $142,970 awarded for that fiscal year; activity R43 (SBIR); PI MOGELSVANG, SOREN; recipient as written: SERPIN PHARMA, LLC, Manassas, VA. Development of new anti-inflammatory peptide source ↗